Published in Brain Behav Immun on April 01, 2003
Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci (2009) 1.58
Effects of cytokines and infections on brain neurochemistry. Clin Neurosci Res (2006) 1.48
Allostasis and the human brain: Integrating models of stress from the social and life sciences. Psychol Rev (2010) 1.44
Early attachment-figure separation and increased risk for later depression: potential mediation by proinflammatory processes. Neurosci Biobehav Rev (2009) 0.97
A biological substrate for somatoform disorders: importance of pathophysiology. Psychosom Med (2007) 0.93
Cytokine involvement in stress may depend on corticotrophin releasing factor to sensitize ethanol withdrawal anxiety. Brain Behav Immun (2011) 0.90
Lack of aggression and anxiolytic-like behavior in TNF receptor (TNF-R1 and TNF-R2) deficient mice. Brain Behav Immun (2010) 0.88
Proinflammatory activity and the sensitization of depressive-like behavior during maternal separation. Behav Neurosci (2011) 0.87
Maternal separation produces, and a second separation enhances, core temperature and passive behavioral responses in guinea pig pups. Physiol Behav (2010) 0.86
Inflammation at the intersection of behavior and somatic symptoms. Psychiatr Clin North Am (2011) 0.83
Influence of depression symptoms on serum tumor necrosis factor-α of patients with chronic low back pain. Arthritis Res Ther (2010) 0.81
Influence of age on behavioral, immune and endocrine responses to the T-cell superantigen staphylococcal enterotoxin A. Eur J Neurosci (2009) 0.79
Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior. Brain Behav Immun (2016) 0.77
Socioeconomic status moderates associations between CNS serotonin and expression of beta2-integrins CD11b and CD11c. J Psychiatr Res (2009) 0.77
Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci U S A (2005) 3.83
GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol Psychiatry (2008) 2.04
Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A (2003) 1.87
Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci (2003) 1.74
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog Neurobiol (2008) 1.61
Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J Neurosci (2007) 1.55
Cytokines, stress and depressive illness: brain-immune interactions. Ann Med (2003) 1.44
Evaluation of the effects of chronic mild stressors on hedonic and physiological responses: sex and strain compared. Brain Res (2003) 1.37
Therapeutic and protective effect of environmental enrichment against psychogenic and neurogenic stress. Behav Brain Res (2006) 1.35
Cytokines as a precipitant of depressive illness: animal and human studies. Curr Pharm Des (2005) 1.30
Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects. J Psychiatry Neurosci (2008) 1.30
Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions. Int J Neuropsychopharmacol (2008) 1.23
Synergistic and additive actions of a psychosocial stressor and endotoxin challenge: Circulating and brain cytokines, plasma corticosterone and behavioral changes in mice. Brain Behav Immun (2008) 1.12
Influence of continuous infusion of interleukin-1beta on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression. Psychopharmacology (Berl) (2008) 1.05
Cytokines as a stressor: implications for depressive illness. Int J Neuropsychopharmacol (2002) 1.04
Major depressive disorder and alterations in insular cortical activity: a review of current functional magnetic imaging research. Front Hum Neurosci (2012) 1.03
Bombesin-like peptides and associated receptors within the brain: distribution and behavioral implications. Peptides (2004) 1.02
Effects of stressors and immune activating agents on peripheral and central cytokines in mouse strains that differ in stressor responsivity. Brain Behav Immun (2010) 1.01
Proinflammatory cytokines differentially influence adult hippocampal cell proliferation depending upon the route and chronicity of administration. Neuropsychiatr Dis Treat (2009) 1.00
Influence of poly I:C on sickness behaviors, plasma cytokines, corticosterone and central monoamine activity: moderation by social stressors. Brain Behav Immun (2007) 0.98
Stress, coping, uplifts, and quality of life in subtypes of depression: a conceptual frame and emerging data. J Affect Disord (2002) 0.97
Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes. Brain Behav Immun (2002) 0.96
Experiential and genetic contributions to depressive- and anxiety-like disorders: clinical and experimental studies. Neurosci Biobehav Rev (2008) 0.95
Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson's disease. Parkinsons Dis (2010) 0.95
Corticotropin releasing hormone receptor alterations elicited by acute and chronic unpredictable stressor challenges in stressor-susceptible and resilient strains of mice. Behav Brain Res (2007) 0.92
Maternal factors and monoamine changes in stress-resilient and susceptible mice: cross-fostering effects. Brain Res (2006) 0.92
Psychosocial stress evoked by a virtual audience: relation to neuroendocrine activity. Cyberpsychol Behav (2007) 0.92
Interferon-alpha effects are exaggerated when administered on a psychosocial stressor backdrop: cytokine, corticosterone and brain monoamine variations. J Neuroimmunol (2007) 0.91
Interferon-γ plays a role in paraquat-induced neurodegeneration involving oxidative and proinflammatory pathways. Neurobiol Aging (2011) 0.91
Molecular pathway reconstruction and analysis of disturbed gene expression in depressed individuals who died by suicide. PLoS One (2012) 0.91
Ethnopharmacology of Q'eqchi' Maya antiepileptic and anxiolytic plants: effects on the GABAergic system. J Ethnopharmacol (2009) 0.90
Soothing the threatened brain: leveraging contact comfort with emotionally focused therapy. PLoS One (2013) 0.90
Inflammatory factors contribute to depression and its comorbid conditions. Sci Signal (2012) 0.88
Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: Neuroimmune sensitization of neurodegeneration. Neurobiol Aging (2008) 0.88
Role of gastrin-releasing peptide and neuromedin B in anxiety and fear-related behavior. Behav Brain Res (2007) 0.87
Interferon-gamma deficiency modifies the effects of a chronic stressor in mice: Implications for psychological pathology. Brain Behav Immun (2009) 0.86
The Role of the Val66Met Polymorphism of the Brain Derived Neurotrophic Factor Gene in Coping Strategies Relevant to Depressive Symptoms. PLoS One (2013) 0.86
Stress and cytokine-elicited neuroendocrine and neurotransmitter sensitization: implications for depressive illness. Stress (2003) 0.86
Altered Organization of GABA(A) Receptor mRNA Expression in the Depressed Suicide Brain. Front Mol Neurosci (2010) 0.84
Antidepressant-like effects of erythropoietin: a focus on behavioural and hippocampal processes. PLoS One (2013) 0.83
Stressor-like effects of c-Jun N-terminal kinase (JNK) inhibition. PLoS One (2012) 0.81
Cyclooxygenase-2 deficiency modifies the neurochemical effects, motor impairment and co-morbid anxiety provoked by paraquat administration in mice. Eur J Neurosci (2008) 0.81
Neurochemical and behavioral responses to inflammatory immune stressors. Front Biosci (Schol Ed) (2009) 0.80
Bombesin receptor regulation of emotional memory. Rev Neurosci (2012) 0.80
The role of gastrin-releasing peptide on conditioned fear: differential cortical and amygdaloid responses in the rat. Psychopharmacology (Berl) (2006) 0.80
Changes in extracellular levels of amygdala amino acids in genetically fast and slow kindling rat strains. Brain Res (2002) 0.80
Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects. J Psychiatry Neurosci (2002) 0.79
Ruminative coping among patients with dysthymia before and after pharmacotherapy. Depress Anxiety (2007) 0.79
Cytokines as potential biomarkers for Parkinson's disease: a multiplex approach. Methods Mol Biol (2012) 0.79
Amygdala amino acid and monoamine levels in genetically Fast and Slow kindling rat strains during massed amygdala kindling: a microdialysis study. Eur J Neurosci (2004) 0.78
Synaptic neurotransmission depression in ventral tegmental dopamine neurons and cannabinoid-associated addictive learning. PLoS One (2010) 0.78
Effects of gastrin-releasing peptide agonist and antagonist administered to the basolateral nucleus of the amygdala on conditioned fear in the rat. Psychopharmacology (Berl) (2008) 0.78
Preferred Features of E-Mental Health Programs for Prevention of Major Depression in Male Workers: Results From a Canadian National Survey. J Med Internet Res (2016) 0.78
Differential impact of audiogenic stressors on Lewis and Fischer rats: behavioral, neurochemical, and endocrine variations. Neuropsychopharmacology (2003) 0.78
Viral-toxin interactions and Parkinson's disease: poly I:C priming enhanced the neurodegenerative effects of paraquat. J Neuroinflammation (2012) 0.77
Neurotrophic paths in the treatment of depression. J Psychiatry Neurosci (2013) 0.77
Anxiety in rats selectively bred for Fast and Slow kindling rates: situation-specific outcomes. Stress (2003) 0.77
The effects of paraquat on regional brain neurotransmitter activity, hippocampal BDNF and behavioural function in female mice. Neurosci Lett (2011) 0.77
Influence of chronic interleukin-2 infusion and stressors on sickness behaviors and neurochemical change in mice. Neuroimmunomodulation (2004) 0.77
Ethnopharmacological investigation of plants used to treat susto, a folk illness. J Ethnopharmacol (2006) 0.77
Effects of acute or chronic omega-3 and omega-6 polyunsaturated fatty acid treatment on behavioral, neuroendocrine and cytokine changes elicited by exogenous interleukin-1beta challenge. J Neuroimmunol (2006) 0.77
Hippocampal neurogenesis, neurotrophic factors and depression: possible therapeutic targets? CNS Neurol Disord Drug Targets (2014) 0.76
Hypoxia alters the expression of inhibitor of apoptosis proteins after brain trauma in the mouse. J Neurotrauma (2007) 0.76
In vivo levels of corticotropin-releasing hormone and gastrin-releasing peptide at the basolateral amygdala and medial prefrontal cortex in response to conditioned fear in the rat. Neuropharmacology (2010) 0.76
A comment on the role of environmental factors in Parkinson's disease. Can J Neurol Sci (2010) 0.75
Illness comorbidity as a biomarker? J Psychiatry Neurosci (2012) 0.75
Souroubea sympetala (Marcgraviaceae): a medicinal plant that exerts anxiolysis through interaction with the GABAA benzodiazepine receptor. Can J Physiol Pharmacol (2014) 0.75
Anxiolytic activity of a supercritical carbon dioxide extract of Souroubea sympetala (Marcgraviaceae). Phytother Res (2011) 0.75
Neurochemical sensitization associated with systemic administration of tumor necrosis factor-alpha: adjuvant action in combination with bovine serum albumin. J Neuroimmunol (2003) 0.75
Characterization of the anxiolytic activity of Nunavik Rhodiola rosea. Planta Med (2013) 0.75
A refined blood collection method for quantifying corticosterone. Lab Anim (NY) (2012) 0.75